Free Peptide Calculator I built because most peptide calculators felt too complicated
peptidecalculatorfree.com · 1 day on the radar
Where is the demand coming from?
Mixed
Some genuine outside demand, some founder reach. This is the read that decides whether the traction would transfer to you.
Roughly what does it earn?
Not disclosedNo basis to estimateWe do not publish a figure until we have something to base it on. When we do, the method that produced it is shown alongside the range.
Could you build it?
Yes, in about 3 days
Nothing patented, no network effect, and no proprietary data set standing in the way.
What it is
A free browser-based peptide dosage calculator that converts prescribed doses into liquid volumes and U-100 syringe markings. The tool targets users mixing reconstituted peptides by simplifying unit conversions that existing calculators obscure behind complexity.
The one thing to knowZero monetization, no founder track record visible, minimal traction signal (single Reddit post), and no structural moat make this a low-priority target despite trivial buildability.
Proof we found, with sources
The scores behind the verdict
Directional reads from public signals, 0 to 100▸ Show the four scores
TractionWeak5 / 100
How much demand shows up from people outside the founder's own circle.
CopyabilityEasy to match92 / 100
How feasible it is for a competent builder to ship something comparable.
Wedge potentialThin15 / 100
How much room is left for a new entrant: gaps, ignored segments, pricing openings.
MonetizationUnproven0 / 100
How much evidence there is that people actually pay: visible pricing, revenue claims, a paid tier in use.
Unlock the full brief
How it works under the hood, how it gets customers, where it is weak, and the opening we would take, with a bottom-line verdict.
Sign in to unlockOne-time payment. Delivered in about a minute. Yours to keep.
Revenue, user and tactic numbers are evidence we found and attributed, with a confidence rating.
They are directional reads, never verified guarantees.